ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Evaluating Exam Review and Guide Q&A

دانلود کتاب ارزیابی بررسی آزمون و راهنمای پرسش و پاسخ

Evaluating Exam Review and Guide Q&A

مشخصات کتاب

Evaluating Exam Review and Guide Q&A

ویرایش:  
نویسندگان:   
سری:  
 
ناشر: Toronto Institute of Pharmaceutical Sciences Inc. 
سال نشر: 2016 
تعداد صفحات: 437 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 8 مگابایت 

قیمت کتاب (تومان) : 48,000



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 11


در صورت تبدیل فایل کتاب Evaluating Exam Review and Guide Q&A به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب ارزیابی بررسی آزمون و راهنمای پرسش و پاسخ نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی درمورد کتاب به خارجی



فهرست مطالب

001 Canadian Pharmacy Review Q&A Content ver1
	Misbah Biabani, Ph.D
	Abbreviations
		Part I: Biomedical sciences
		Part II: Pharmaceutical Sciences
		Part III: Social / Behavioural /Administrative Sciences
01 Chapter Human Anatomy Q&A
02 Gastrointestinal System Q&A
	1. A person with Vitamin B12 deficiency due to intrinsic factors. Should take?
		C) Patient is using NSAIDs
03 Chapter Nervous System Q&A
04 Chapter Cardiovascular System Q&A
05 Chapter  Endocrine System Q&A ver1
	ENDOCRINE SYSTEM
		A. Sensitivity to cold
			D. Constipation
				B) refer to doctor to decrease dose of Synthroid
		6. Which of the following stimulates secretion of calcitonin hormone from
			C) Hypokalemia
06 Chapter Renal System Q&A ver1
	RENAL DISORDERS
07 Chapter Liver functions and Chronic Liver Diseases Q&A ver1
	E. None of the above
		B. Cholecystitis
			D. Hepatic encephalopathy
			E) Liver cirrhosis
08 Chapter Respiratory System Q&A ver1
	RESPIRATORY COMPLICATIONS
		E) Bronchial cavity
09 Chapter Urinary System Q&A
	Pharmacy Prep
	Urinary System
10 Chapter The Eye and Ear Q&A
	D. Optic nerve
	Ans: A
	E. None of the above
	A) Cones
	Ans. B
11 Chapter Blood and Anemia Q&A
	Ans: A
	Ans: B
12 Chapter Biochemistry Q&A ver1
13 Chapter Fluids Electrolytes and Nutrition Q&A ver1
	PHARMACY PREP
		NUTRITION
14 Chapter Microbiology Q&A ver1
	PHARMACY PREP
		MICROBIOLOGY
15 Chapter Cell and Molecular Biology Q&A ver1
	CELL AND MOLECULAR BIOLOGY
		C) Same time as transcription
	A) factor 5 B) factor10 C) factor 8 D) factor 2 E) factor 9
	X
	X
		xy
	C. Oxidoreductases
16 Chapter Pharmacogenetics Q&A
	D) The pharmacogenetics identifies the genetic variation that cause drug cause differences in drug response.
	E) All of the above
17 Chapter Immunology and Immunization Q&A ver 1
	IMMUNOLOGY and Immunizations
18 Chapter Biotechnology Q&A ver1
	BIOTECHNOLOGY
		B. Tumor necrosis factor alpha inhibitor
		C) thrombocytopenia associated with cancer chemotherapy
			E) chemotherapy induced anemia
		Ans: A
		Ans. A
	9) Operlaveukin (IL-11) is indicated for?
		Ans. A
		C. Thrombocytopenia associated with cancer chemotherapy
		D. Anemia associated with chronic renal diseases
	E. None of the above
	HAMA is?
		B) Humanized chain linked to rat chain
			D) One quarter the antibody is from one species origin where
19 Chapter Toxicology Q&A ver1
	TOXICOLOGY
		B. Myoglobin
		Ans. A
	BIBLIOGRAPHIC REFERENCE
20 Chapter Pharmacokinetic  Q&A ver 1
	PHARMACOKINETICS
	K = 0.693/0.7 = 0.999
		B.936 mg/hr
			Cloxacillin 50%                      50%
				Ans-B
	Enter 64
		Multiply
	Drug Dose
		Form
	Product Company
21 Chapter Rates and orders of reaction Q&A ver1
	RATES AND ORDERS OF REACTIONS
22 Chapter Pharmacodynamics Q&A ver1
	D. Concentration of AgE and Ag*E increase
23  Chapter Medicinal Chemistry Basics Q&A ver1
	MEDICAL CHEMISTRY
		D) Proline ring
	E) Carbamate group
24 Chapter Medicinal Chemistry of Autonomic Nervous System Q&A ver 1
	Pharmacy Prep
	Medicinal Chemistry of Autonomic Nervous System
25 Chapter Medicinal chemistry of autocoids, NSAID and Opioid analgesics Q&A ver1
26 Chapter Medicinal Chemistry and Pharmacology of Cardiovascular Drugs Q&A ver1
	MEDICINAL CHEMISTRY AND PHARMACOLOGY OF CARDIOVASCULAR SYSTEM
		B. Warfarin
		D) Proline ring
		B. Digoxin
		B. Ischemic stroke
27 Chapter Medicinal chemistry and pharmacology of psychiatric and neurological drugs
28 Chapter Medicinal Chemistry and Pharmacology of Endocrine System Q&A
29 Chapter Medicinal Chemistry and Pharmacology of Respiratory Drugs
30 Chapter Medicinal Chemistry and Pharmacology of Musculoskeletal Drugs Q&A
31 Chapter Medicinal Chemistry and Pharmacology of antimicrobials
32 Chapter Metabolism Q&A ver1
	METABOLISM
33 Chapter Biopharmaceutics Q&A ver1
	BIOPHARMACEUTICS
	A-100% solute is ionized
	Ans. C
	14. A drug degradation at room temperature is determined by?
	A. Noye-Whittney equation
	B. Arrhenius equation
34 Chapter Pharmaceutics Q&A ver1
	Physical Pharmacy
35 Chapter Pharmaceutical Exipients Q&A
36 Chapter Rheology Q&A ver1
	RHEOLOGY
37 Chapter Pharmaceutical dosage forms Q&A  ver 1
	PHARMACEUTICAL DOSAGE FORMS
38 Chapter Drug Delivery Systems Q&A ver1
	DRUG DELIVERY SYSTEMS
39 Pharmaceutical analysis Q&A ver1
	PHARMACEUTICAL   ANALYSIS
		II- Addition of a specific buffer will increase the reaction
	ANSWERS
	BIBLIOGRAPHIC REFERENCE
40 Chapter Canadian Healthcare System Q&A
41 Chapter Pharmacy Regulations Q&A ver1
42 Chapter Social Behavioral aspects of pharmacy profession
43 Chapter Pharmacy Practice Management Q&A ver1
	PHARMACY PREP
	PHARMACY MANAGEMENT
	B. Sole proprietorship
		D. Oligopolistic competition
			Beginning inventory $200,000
		PHARMACY PRACTICE MANAGEMENT
	Tips: [Sales - COGS/Sales] x 100
44 Chapter Pharmacoeconomics Q&A ver1
	PHARMACOECONOMICS
		A. Quality unit
		6. Pharmacoeconomic studies are used to analyze cost of drugs to:
		A. Healthcare system
		A. Quality unit
		11. Pharmacoeconomic studies are used to analyze cost of drugs to:
		A. Healthcare system
	PHARMACOECONOMICS
		6. Ans: B
		11. Ans: B
45 Chapter Drug discovery and new drug approval process Q&A
46 Chapter Epidemiology and clinical studies Q & A
	EPIDEMIOLOGY and Clinical Studies
47 Chapter Biostatistics Calculations Q&A ver1
	BIOSTATISTICS  CALCULATIONS
48 Chapter Hospital Pharmacy
49 Chapter Basic Calculations ver1
	Basic CALCULATIONS
	3.A patient weight 180 lbs has admitted to emergence for congestive heart failure and severe edema. Patient was give furosemide iv infusion for the past 24 hours. After discharge the patient weight was 173 lbs. How many kg patient weight is lost?
50 Chapter Dose Calculations
	Provera 5 mg tab QD
		Ans: E
		Ans: D
		Ans: D
		Ans-C
	Ans. C
	A. 300 mg
	Total therapy 21 days
51 Chapter Dilutions and concentrations Q&A ver1
52 Chapter Brand and Generic Name Indexes Q&A
53 Chapter Prescription Processing and Dispensing Q&A ver1
	PHARMACY PREP
54 Chapter Safety of drug use in special populations Q&A ver1
	DRUGS IN SPECIAL POPULATIONS
55 Chapter Clinical Toxicology Q&A
	A) S-adenosyl transferase
56 Chapter Professional Communication skills Q&A ver1
	PHARMACY PREP
	PHARMACY COMMUNICATION SKILLS
57 Chapter Bioethics and Professional Standards Q&A ver1
	1. The ethical standard beneficence in pharmacy practice means:
	A. Pharmacist act with justice
	2. The ethical standard nonmaleficence in pharmacy practice means:
	A. Pharmacist act with justice
	3. The ethical standard veracity in pharmacy counselling means:
	A. Pharmacist act with justice
	4. The ethical standard justice in pharmacy practice means:
	A. Pharmacist act with equality
	E) Veracity
	A. Discard the sterile preps and redo new batch
	A. Beneficence
	B. Nonmaleficence
	C.  veracity
	D. Justice
	E.  Autonomy
		C) Verify and give patient profile to EMS, it is in best interest of patient.
	1. D
	2. E
	3. C
	4. B
	Tips:  It is circle of care, you can share information after confirmation.
58 Chapter Drug Information Sources Q&A
	B. A Canadian pharmacy journal
59 Chapter Medication Errors Q&a
	B-Calm down patient
60 Chapter Health Promotion and Disease Prevention Q&A
61 Chapter Collaboration and Teamwork Q&A
62 Chapter Sterile Preparations Q&A
	STERILE PREPARATIONS
	A-Horizontal laminar airflow hood
	B-Vertical Laminar airflow hood
63 Chapter Pharmaceutical Storage Conditions Q&A
64 Chapter Pharmaceutical Care and Drug Related Problems Q&A
65 Chapter Adverse Drug Reactions Q&A ver1
	PHARMACY PREP
66 Chapter Drug  Interactions Q&A ver1
	DRUG & DRUG INTERACTIONS
		E) Call the doctor, change to levofloxacin.
		D. None of the above
	DRUG & DRUG INTERACTIONS
67 Chapter Clinical Biochemistry Q&A
	CLINICAL BIOCHEMISTRY
	B. Sensitive TSH assay
		A. Creatinine clearance
		CLINICAL BIOCHEMISTRY
			13. Ans: A
68 Chapter Therapeutic Drug Monitoring Q&A ver1
	1-Which antipsychotic drugs monitored for WBC or CBC?
	D-Haloperidol
	3) Patient using statins should be monitored for?
	A-LFT and CK-MM
	1) Ans: B
	3) Ans: A
69 Chapter OTC drugs for skin conditions Q&A
	B-Calamine lotion
	D-II and III only
		10-What is incorrect in treatment of diaper rash?
		B-clean diaper area with alcohol swabs
		10- Ans: B
70 Chapter OTC and Prescription Drugs for Ophthalmic, Ear and Mouth Disorders Q&A
	1. What is an optimal range of pH for ophthalmic products
		5. What is correct statement about treatment in eruption cysts in infants
			III-antibiotics
	I- Increase of IOP
	1.Ans: D
		5. Ans: A
71 Chapter OTC antihistamines, decongestants, antitussives  Q&A
	OTC ANTIHISTAMINE, DECONGESTANTS AND ANTITUSSIVES
		E-Mydriasis
		A-recommend ASA
	OTC ANTIHISTAMINE, DECONGESTANTS AND ANTITUSSIVES
72 Chapter OTC drugs for nausea, vomiting, constipation, diarrhea, hemorrhoids and helmenths Q&A
73 Chapter OTC drugs for headache, sports injuries, pressure ulcer, and low back pain Q&A
	A-Irreversible inhibition of platelet aggregation
74 Chapter Asthma and COPD Q&A
75 Chapter Smoking cessation Q&A
	PHARMACY PREP
	SMOKING CESSATION
	2) Nicotine patches are stored in?
	A-Refrigerator   B-Room temperature   C-Cold temperature
	D-Freezer   E-Any temperature
	A. Stored in room temperature
	D-Avoid in sexual dysfunction
		E. Nicotine gum
	SMOKING CESSATION
	2) Ans:  B
76 Chapter Sleep Disorders Q&A
	E-Chlorozepate
77 Chapter Eating Disorders Q&A
	B)Weight in kg/height in meters
78 Chapter Gastrointestinal system Q&A
	GASTROINTESTINAL DISORDERS
		I- Villi
		III- They decrease stomach acid secretion
		III- Taken 2hrs before bedtime
		II- Aluminum hydroxide
			E) sucralfate
		GASTROINTESTINAL DISORDERS
		ANSWERS
79 Chapter Diabetes Q&A ver1
	PHARMACY PREP
	DIABETES
	A-I only
	E-May cause anorexia
	13-What is correct about sulfonylureas?
	E-Glyburide
	E-Glyburide
		DIABETES
	13- Ans: E
80 Chapter Thyroid disorders Q&A ver1
	E-Hypothyroidism(Graves disease
	A-Tetraiodinase enzyme
		III) Decreased TSH levels
			C) Should not be cut
	14-What is the most common side effects of propylthiouracil?
	D-platelet aggregation
	E-diarrhea
	C-Iron supplements
	D-Excessive Soya fiber
	14- Ans: C
81 Chapter Contraception Q&A
	E-Justice
		E-Refer to doctor
82 Chapter Genitourinary and Gynecology Conditions Q&A ver1
	GENITOURINARY CONDITIONS
	A-Nocturia
	III-vitamins, and estrogens deficiency may cause PMS
	A-Hydrochlorthiazide
	C-Call doctor to change other antibiotic
		D-all of the above
			D) None of the above
		26. What is the drug of choice to treat patient with vaginal pruritus, curdy vaginal discharge, no odor and no color discharge?
83 Chapter Bones and joints complications Q&A ver1
84 Chapter Osteoporosis Q&A
85 Chapter Hypertension Q&A
	C-200 mm Hg
	D-120 mm Hg
86 Chapter Coronary artery Disease (CAD) Q&A
	A-Amiodarone
	10) All of the following are low molecular weight heparins (LMWH), except?
	11) What is not true about low molecular weight heparins
	(LMWH)?
	A-It act by inhibiting factor Xa
	10) E(was D before)
	11) D
87 Chapter Stroke Q&A
88 Chapter Congestive Heart Failure (CHF) Q&A
	PHARMACY PREP
89 Chapter Antiarrhythmic drugs Q&A
90 Chapter Peripheral Vascular Diseases Q&A
	13) Which of the of the following can be used in a pregnant women with deep vein thrombosis ?
	E)Reynaud phenomenon is may occur in old age
	D) diabetes
	13) Ans:  D
91 Chapter Anticoagulants Q&A
92 Chapter Anti anxiety Disorder  Q&A
93 Chapter Depression Q&A
	D) Serotonin withdrawal syndrome
94 Chapter Psychosis Q&A
95 Chapter Dementia Q&A
	13)What is incorrect statement?
96 Chapter Seizure and antiepileptic drugs Q&A
	B-Complex partial
	C-Simple partial
		E) Absence seizure (petit mal)
			E-Valproic acid
			C-Tiagabine
		E-Phenobarbital
	25) All of the following are GABA analogs except?
	25) Ans: E
97 Chapter Parkinsons Disease Q&A
	E-Pseudo parkinsonism
	B-MAO-B selective inhibitor
	A-COMT inhibitor decrease metabolism of levodopa to 3-O-methyldopa
	10-Tardive Dyskinesia is?
	B-Involuntary movement of limbs, trunk, mouth and face
	38) Parkinson’s disease is caused by deficiency of?
	1- Ans: A
	10- Ans: B
	38) Ans: A
98 Chapter Anti-infective agents Q&A
	2.What is empiric treatment of urinary tract infection, patient has allergy to penicillin?
	A. cotrimoxazole 3 d
	B. Fluroquinolone 3d
	C. Amoxicillin 3 d
	D. Cephalexin 7 d
	E. Aminoglycoside 14 d
	Ans. A
99 Chapter Anticancer drugs and Chemotherapy Q&A
	A-Mesna
	B-Doxarazoxane
	C-Chlropropamide
	D-Erythropoeitins
		4) The drug of choice to treat delayed nausea and vomiting?
		A-Ondansetron
		B-Metoclopramide
		C-Dexamethasone
		D-Dimenhydrinate
			E-Scopolamine
100 Chapter Natural Products and Pharmacognosy Q&A




نظرات کاربران